Jacobs Levy Equity Management, Inc I Teos Therapeutics, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 205,863 shares of ITOS stock, worth $1.51 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
205,863
Previous 176,314
16.76%
Holding current value
$1.51 Million
Previous $2.62 Million
19.69%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ITOS
# of Institutions
166Shares Held
36.6MCall Options Held
1.95MPut Options Held
374K-
Black Rock Inc. New York, NY3.73MShares$27.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.18MShares$23.4 Million0.45% of portfolio
-
Boxer Capital, LLC San Diego, CA2.95MShares$21.7 Million1.6% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$20.1 Million19.24% of portfolio
-
Tang Capital Management LLC San Diego, CA2.41MShares$17.7 Million2.09% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $261M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...